APOE ε4与青光眼的负相关受系统性高血压修饰:加拿大老龄化纵向研究
基于加拿大老龄化纵向研究24,655名45至85岁欧洲血统成年人,携带APOE ε4等位基因与青光眼患病风险降低相关(OR=0.83;95%CI 0.69-0.98;P=0.033)。该关联仅在无系统性高血压者中显著(OR=0.62;95%CI 0.46-0.85),在有高血压者中无显著关联(OR=0.97;95%CI 0.79-1.21),交互项P=0.017;APOE ε4与眼压无关联(β=-0.01;95%CI -0.13至0.10)。
要点
- 携带APOE ε4等位基因与青光眼患病风险降低相关(OR=0.83;95%CI 0.69-0.98)。
- 该负相关仅在无系统性高血压者中显著(OR=0.62;95%CI 0.46-0.85),有高血压者中无显著关联(OR=0.97;95%CI 0.79-1.21)。
- APOE ε4与角膜补偿眼压无关联(β=-0.01;95%CI -0.13至0.10)。
核心结论
- APOE ε4等位基因与青光眼患病风险降低相关,但该关联仅限于无系统性高血压者。
- 需要进一步研究以理解这些发现的生物学机制及其治疗潜力。
研究设计与样本
- 数据来自加拿大老龄化纵向研究,为基于人群的研究,纳入欧洲血统队列24,655名45至85岁成年人。
- APOE基因型由单核苷酸多态性rs429358和rs7412推导。
- 参与者被询问是否曾被医生诊断青光眼,并使用Reichart眼反应分析仪测量角膜补偿眼压。
主要发现
- 调整年龄、性别、眼压和前10个群体结构主成分后,携带APOE ε4等位基因与青光眼患病风险降低相关(OR=0.83;95%CI 0.69-0.98;P=0.033)。
- 交互作用分析显示,携带APOE ε4等位基因仅在无系统性高血压者中与青光眼相关(OR=0.62;95%CI 0.46-0.85),在有系统性高血压者中无显著关联(OR=0.97;95%CI 0.79-1.21),交互项P=0.017。
- APOE ε4与眼压无关联(β=-0.01;95%CI -0.13至0.10)。
局限性
- 原文结论指出需要进一步研究以理解这些发现的生物学机制及其治疗潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Studies examining the apolipoprotein E (APOE) ε4 allele and glaucoma are inconsistent, which could be due to interactions with other factors. We examined the relationship between the APOE ε4 allele and glaucoma and intraocular pressure in a large, population-based random sample and explored whether the APOE ε4 allele interacted with systemic hypertension. METHODS: Data came from the Canadian Longitudinal Study on Aging, a population-based study that included 24,655 adults ages 45 to 85 years old in the European ancestry cohort. APOE genotypes were derived from single-nucleotide polymorphisms rs429358 and rs7412. Participants were asked about a prior diagnosis of glaucoma from a doctor. Corneal compensated intraocular pressure (IOP) was measured using the Reichart Ocular Response Analyzer. RESULTS: Having an APOE ε4 allele was associated with a lower odds of glaucoma after adjusting for age, sex, IOP, and the top 10 population structure principal components (odds ratio [OR] = 0.83; 95% confidence interval [CI], 0.69-0.98; P = 0.033). A novel statistically significant interaction was found in that having an APOE ε4 allele was only associated with glaucoma in those without systemic hypertension (OR = 0.62; 95% CI, 0.46-0.85) although it was not associated in those with it (OR = 0.97; 95% CI, 0.79-1.21) (interaction term P value = 0.017). APOE ε4 was not associated with IOP (β = -0.01; 95% CI, -0.13 to 0.10). CONCLUSIONS: Evidence increasingly points to the APOE ε4 allele having protective benefits against glaucoma, but this association was limited to those without systemic hypertension. Further research is needed to understand the biological mechanisms for these findings and the treatment potential they hold.
引用
- Freeman EE, Bastasic J, Grant A, et al. Inverse Association of APOE ε4 and Glaucoma Modified by Systemic Hypertension: The Canadian Longitudinal Study on Aging. Invest Ophthalmol Vis Sci. 2022. PMID: 36479943. doi:10.1167/iovs.63.13.9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。